Abstract
When the CHC13 extract obtained by partitioning the methanolic extract of Periploca sepium between H20. and CHC13 was subjected to column chromatography on silica gel, the antitumor activity against Sarcoma 180 ascites in mice was concentrated in the fraction eluted with CHC13-MeOH (10:1). From the antitumor fraction, eight products, S-l—S-8, were isolated. S-l was identified as 12β-hydroxypregna-4,6,16-triene-3,20-dione (neridienone-A), obtained for the first time from Asclepiadaceous plants, by direct comparison with an authentic sample and the others were found to be steroidal glycosides. A new compound S-2A (named periplocogenin), and two known aglycones S-3A and S-5A, obtained by hydrolyzing the above glycosides with diluted acid, were respectively identified as 3β-0-(4’,6’-dideoxy-3’-O-methyl-/l3-D-2’-hexosulosyl)-d5-pregnene-17α,20(5)-diol, periplogenin, and △5-pregnene-3β,20(5)-diol from the proton and carbon-13 nuclear magnetic resonance spectral data. The structure of S-6A was identical with that of S-5A, and S-7A and S-8A were identical with S-2A.
Original language | English (US) |
---|---|
Pages (from-to) | 4524-4529 |
Number of pages | 6 |
Journal | Chemical and Pharmaceutical Bulletin |
Volume | 35 |
Issue number | 11 |
DOIs | |
State | Published - 1987 |
Externally published | Yes |
Keywords
- Periploca sepium
- antitumor activity
- neridienone-A
- periplocogenin
- periplogenin
- △-pregnene-3β,20(5)-diol
ASJC Scopus subject areas
- General Chemistry
- Drug Discovery